Solventum Co. (NYSE:SOLV) Given Average Rating of “Hold” by Brokerages

Solventum Co. (NYSE:SOLV) has been assigned an average rating of “Hold” from the eleven ratings firms that are currently covering the company, MarketBeat.com reports. One investment analyst has rated the stock with a sell rating, nine have assigned a hold rating and one has issued a buy rating on the company. The average 12-month price objective among brokerages that have covered the stock in the last year is $68.29.

A number of equities analysts recently issued reports on SOLV shares. Morgan Stanley upped their price target on Solventum from $60.00 to $73.00 and gave the company an “equal weight” rating in a report on Monday, November 11th. Mizuho initiated coverage on Solventum in a research report on Wednesday, December 4th. They set a “neutral” rating and a $70.00 target price on the stock. Stifel Nicolaus initiated coverage on Solventum in a research note on Tuesday, October 8th. They issued a “buy” rating and a $82.00 price objective for the company. Wolfe Research started coverage on shares of Solventum in a research report on Thursday, September 26th. They issued a “peer perform” rating for the company. Finally, Piper Sandler boosted their price target on Solventum from $71.00 to $75.00 and gave the company a “neutral” rating in a research report on Friday, November 8th.

Solventum Trading Down 0.8 %

Shares of SOLV stock opened at $68.87 on Friday. Solventum has a 12 month low of $47.16 and a 12 month high of $96.05. The company has a current ratio of 1.15, a quick ratio of 0.83 and a debt-to-equity ratio of 2.45. The firm has a fifty day moving average price of $69.42 and a 200 day moving average price of $64.69.

Hedge Funds Weigh In On Solventum

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in SOLV. Hollencrest Capital Management acquired a new position in Solventum in the 2nd quarter valued at $25,000. Modus Advisors LLC acquired a new stake in shares of Solventum during the 4th quarter worth $25,000. Copeland Capital Management LLC acquired a new position in Solventum in the third quarter valued at $26,000. Mather Group LLC. purchased a new stake in Solventum during the third quarter valued at about $27,000. Finally, Studio Investment Management LLC purchased a new position in shares of Solventum in the 2nd quarter worth about $29,000.

Solventum Company Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.